Abercrombie & Fitch (ANF): Assessing Valuation After a Sharp One-Month Rebound

Abercrombie & Fitch (ANF) has been on traders’ radar after a sharp rebound, with the stock up about 42% over the past month even as the year-to-date return remains negative.

See our latest analysis for Abercrombie & Fitch.

That 42% 1 month share price return has only partly clawed back this year’s slide. With a three year total shareholder return above 320%, the recent bounce signals momentum is tentatively rebuilding after a bruising reset.

If ANF’s rebound has you thinking about what might run next, it could be worth exploring fast growing stocks with high insider ownership as a hunting ground for the market’s next set of standouts.

With Abercrombie & Fitch now trading just below analyst targets after a blistering multi year run, the real question is whether the recent pullback leaves upside on the table, or if markets are already pricing in the next leg of growth.

Most Popular Narrative: 7.2% Undervalued

With Abercrombie & Fitch last closing at $99.61 against a narrative fair value near $107, the current price sits noticeably below the implied long term outlook.

The analysts have a consensus price target of $114.625 for Abercrombie & Fitch based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $145.0, and the most bearish reporting a price target of just $84.0.

Read the complete narrative.

Want to see how modest revenue growth, easing margins, and a richer future earnings multiple still add up to upside from here? The full narrative reveals the playbook.

Result: Fair Value of $107.33 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, rising tariffs and continued margin pressure from heavier promotions could quickly undermine the upbeat growth story that analysts are leaning on today.

Find out about the key risks to this Abercrombie & Fitch narrative.

Build Your Own Abercrombie & Fitch Narrative

If you see the story differently, or would rather dig into the numbers yourself, you can craft a personalised view in just minutes with Do it your way.

A great starting point for your Abercrombie & Fitch research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.

Looking for your next investing edge?

Turn this momentum into a smarter watchlist by acting now on focused stock ideas from the Simply Wall St screener, before the crowd rushes in.

• Capitalize on market mispricing with these 916 undervalued stocks based on cash flows that combine solid fundamentals with attractive entry points others may be overlooking.
• Ride structural growth trends by targeting these 30 healthcare AI stocks at the intersection of innovation and long term demand for medical breakthroughs.
• Accelerate your search for yield by scanning these 14 dividend stocks with yields > 3% that aim to deliver steady income while still offering room for capital appreciation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com